EMAIL THIS PAGE TO A FRIEND

Biochemical pharmacology

Polyoxometalates--potent and selective ecto-nucleotidase inhibitors.


PMID 25449596

Abstract

Polyoxometalates (POMs) are inorganic cluster metal complexes that possess versatile biological activities, including antibacterial, anticancer, antidiabetic, and antiviral effects. Their mechanisms of action at the molecular level are largely unknown. However, it has been suggested that the inhibition of several enzyme families (e.g., phosphatases, protein kinases or ecto-nucleotidases) by POMs may contribute to their pharmacological properties. Ecto-nucleotidases are cell membrane-bound or secreted glycoproteins involved in the hydrolysis of extracellular nucleotides thereby regulating purinergic (and pyrimidinergic) signaling. They comprise four distinct families: ecto-nucleoside triphosphate diphosphohydrolases (NTPDases), ecto-nucleotide pyrophosphatases/phosphodiesterases (NPPs), alkaline phosphatases (APs) and ecto-5'-nucleotidase (eN). In the present study, we evaluated the inhibitory potency of a series of polyoxometalates as well as chalcogenide hexarhenium cluster complexes at a broad range of ecto-nucleotidases. [Co4(H2O)2(PW9O34)2](10-) (5, PSB-POM142) was discovered to be the most potent inhibitor of human NTPDase1 described so far (Ki: 3.88 nM). Other investigated POMs selectively inhibited human NPP1, [TiW11CoO40](8-) (4, PSB-POM141, Ki: 1.46 nM) and [NaSb9W21O86](18-) (6, PSB-POM143, Ki: 4.98 nM) representing the most potent and selective human NPP1 inhibitors described to date. [NaP5W30O110](14-) (8, PSB-POM144) strongly inhibited NTPDase1-3 and NPP1 and may therefore be used as a pan-inhibitor to block ATP hydrolysis. The polyoxoanionic compounds displayed a non-competitive mechanism of inhibition of NPPs and eN, but appeared to be competitive inhibitors of TNAP. Future in vivo studies with selected inhibitors identified in the current study are warranted.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

L9756
(−)-Tetramisole hydrochloride, ≥99% (GC)
C11H12N2S · HCl
L1881
1-Oleoyl-sn-glycero-3-phosphocholine, synthetic, ≥99%
C26H52NO7P
C2885
CHES, ≥99.0% (titration)
C8H17NO3S
C8210
CHES, BioXtra, ≥99.0% (titration)
C8H17NO3S
29311
CHES, BioUltra, ≥99.5% (T)
C8H17NO3S
RES1299C-B7
CHES, PharmaGrade, Manufactured under appropriate controls for use as a raw material in pharma or biopharmaceutical production., suitable for cell culture
C8H17NO3S
457116
Decane, anhydrous, ≥99%
C10H22
30540
Decane, analytical standard
C10H22
30550
Decane, purum, ≥98.0% (GC)
C10H22
442669
Decane, analytical standard
C10H22
D901
Decane, ReagentPlus®, ≥99%
C10H22
30570
Decane, ≥95%
C10H22
D8885
Diethanolamine, reagent grade, ≥98.0%
C4H11NO2
31589
Diethanolamine, BioUltra, ≥99.5% (GC)
C4H11NO2
16957
Diethanolamine, analytical standard
C4H11NO2
D0681
Diethanolamine, BioXtra, ≥98.5%
C4H11NO2
31590
Diethanolamine, puriss. p.a., ACS reagent, ≥99.0% (GC)
C4H11NO2
398179
Diethanolamine, ACS reagent, ≥98.5%
C4H11NO2
PHR1220
Diethanolamine, Pharmaceutical Secondary Standard; Certified Reference Material
C4H11NO2
02424
Ethanesulfonic acid, purum, ≥99.0% (T)
C2H6O3S
186260
Ethanesulfonic acid, 95%
C2H6O3S
471550
Ethanesulfonic acid solution, 70 wt. % in H2O
C2H6O3S
31742
Levamisol hydrochloride, VETRANAL, analytical standard
C11H12N2S · HCl
L0380000
Levamisole hydrochloride, European Pharmacopoeia (EP) Reference Standard
C11H12N2S · HCl
Y0000047
Levamisole hydrochloride for system suitability, European Pharmacopoeia (EP) Reference Standard
C11H12N2S · HCl
31960
N,N-Diethylaniline, puriss. p.a., ≥99.5%
C10H15N
31970
N,N-Diethylaniline, purum, ≥98.0% (GC)
C10H15N
185868
N,N-Diethylaniline, ≥99%
C10H15N
80621
Piperazine, BioUltra, anhydrous, ≥99.0% (T)
C4H10N2
94209
Piperazine, analytical standard
C4H10N2